March/April has been the guidance for the data release. That has been known for awhile for anyone that has listened to the Company. As for "risks", if the data is solid the Company will be in a massive sprint to launch in Q1 of next year. They've already been preparing. One look at their Job Openings section on their website will tell you as much. Their lab in Madison is becoming CLIA approved. The execution risk is GONE, if the data comes in solid with the primary endpoint being Cologuard vs Colonoscopy and the secondary endpoint being Cologuard vs FIT for detection of cancers AND pre-cancers. As for Sales traction, I think that you'd be surprised to learn (if you listened to a conference call or presentation made by the management team) that 60% of the FIT tests out there are generated by just 6% of the primary care physicians. That means that just 6% control about 6 million annual FIT tests. It won't be difficult targeting those 6%. What is really the KEY here is CMS reimbursement. And this is a unique situation given that CMS has invited EXAS into a pilot-program by which CMS reimbursement will occur no later than 90 days after FDA approval. This is unheard of. It usually takes anywhere from 18-24 months AFTER FDA approval, for CMS to approve reimbursement. And that has been the "killer" in the past for medical diagnostic companies. This is ALL PUBLIC INFORMATION. It's mind-boggling that some of the people here that have capital at risk are clueless to the fundamental basics and refuse to spend 30 minutes listening to the last earnings call from February ... yet don't hesitate to make grandiose unsubstantiated claims. Strange.
"grandiose unsubstantiated claims" That seems like a grandiose and unsubstantiated accusation. I haven't seen any claims at all actually. As for the earnings call.... I never listen to those. It takes too long to find out too little. I wait for the analysts to sift through and tell me what was said. I follow way too many stocks to sit around and listen to the self-absorbed hemming and hawing. I just want the bottom line. I like Aticus's approach as he seems to use option prices to guage the degree of optimisim/pessimism... and to show a target. Makes sense to me. If you are so uncomfortable with the dummies on this board why do you post here?? Certainly it's not to get any information or opinions from us. Maybe it's just a place for you to exercise your stunted ego. I bet you are 5'2'' wear glasses, live with your mother and have a cat.
Nice little hammer bottom today... Shook the Tree down to 9.80 and came back to as high as 10.28 just before the close at 10.24
EXAS just announced they wil announce "preliminary top line results of its DeeP-C pivotal clinical trial" Thursday monring at 7:30AM ET. Here is a URL to the story: http://finance.yahoo.com/news/exact-sciences-schedules-announcement-call-224500983.html Share price is up to 10.99 after hours. It looks like all my shares will be called away. I would have preferred EXAS to have waited until next Tuesday so I could have left half uncovered.